Clinical Trials Directory

Trials / Completed

CompletedNCT00460369

Treatment of Uncomplicated Malaria in Benin

Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine Versus Amodiaquine-Artesunate Coformulation in Uncomplicated Plasmodium Falciparum Malaria : an Open Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Institut de Recherche pour le Developpement · Other Government
Sex
All
Age
6 Months – 119 Months
Healthy volunteers
Not accepted

Summary

Malaria is a life-threatening disease especially in small children. A high degree of Plasmodium falciparum resistance to chloroquine has already spread to South-Benin where this study is taking place. In the past few years, the recommendation for a first-line treatment in this area has moved from chloroquine to sulfadoxine-pyrimethamine (SP). There is growing evidence that Plasmodium falciparum resistance to SP has come to South-Benin. The aim of the study is to compare the efficacy of SP to two compact artemisinin-based therapies (ACT): artemether-lumefantrine and the amodiaquine-artesunate coformulation. ACT will be unsupervised. The primary endpoint is an effectiveness comparison (PCR corrected) at day 28. Secondary outcomes are effectiveness comparisons (PCR corrected) at day 14 and 42 and a study on the relationships between ACT PK data (day 3) and outcome. Expected total enrollment: 225 patients Study start: April 2007; expected completion: December 2007

Conditions

Interventions

TypeNameDescription
DRUGsulfadoxine-pyrimethaminetablets 1,25/25 mg 1 tablet per 20 kg of body weight Single drug intake
DRUGartemether-lumefantrinetablets 20/120 mg * 1 tablet twice daily for 3 days below 15 kg of bodyweight * 2 tablets twice daily for 3 days below 24 kg of bodyweight * 3 tablets twice daily for 3 days below 35 kg of bodyweight
DRUGamodiaquine-artesunate coformulationone 25mg/67,5mg tablet, once daily for 3 days below 9 kg one 50/135mg tablet, once daily for 3 days below 18 kg

Timeline

Start date
2007-04-01
Primary completion
2007-11-01
Completion
2007-11-01
First posted
2007-04-13
Last updated
2008-04-14

Locations

1 site across 1 country: Benin

Source: ClinicalTrials.gov record NCT00460369. Inclusion in this directory is not an endorsement.